外泌体CTLA-4经PTEN/CD44通路促进脾虚肝癌侵袭转移
该研究将40只小鼠随机分为对照、脾虚、肝癌、脾虚肝癌四组,以利血平诱导加原位移植建立脾虚肝癌模型,发现脾虚肝癌组外泌体中CTLA-4、PD-1、PTEN、AKT蛋白表达上调,外泌体转移与自我更新更具侵袭性,加CTLA-4抑制剂可部分逆转,机制为CTLA-4调控PTEN/CD44通路。
要点
- 脾虚内环境下肝癌外泌体CTLA-4表达上调,促进肿瘤侵袭转移。
- CTLA-4抑制剂可部分逆转脾虚肝癌外泌体的侵袭与自我更新。
- CTLA-4经PTEN/CD44通路介导脾虚促肝癌进展。
核心结论
- 脾虚内环境下外泌体CTLA-4调控PTEN/CD44信号通路,促进肝癌增殖、自我更新与转移。
研究设计与样本
- 40只小鼠随机分为对照、脾虚、肝癌、脾虚肝癌四组。
- 采用利血平诱导加原位移植建立脾虚肝癌模型。
- 用细胞增殖、凋亡、划痕和Transwell实验研究脾虚对肝癌细胞增殖、凋亡、侵袭和转移的影响。
主要发现
- 与肝癌组相比,脾虚肝癌组外泌体中CTLA-4、PD-1、PTEN、AKT蛋白表达上调。
- 脾虚肝癌组外泌体的转移与自我更新比肝癌组更具侵袭性。
- 加入CTLA-4抑制剂可部分逆转上述侵袭性。
临床怎么用
- 脾虚证肝癌患者可能存在外泌体CTLA-4相关通路激活,可关注CTLA-4抑制策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is one of the most common primary cancers, and its pathogenesis is complicated and difficult to screen. Currently, there is no effective treatment. In traditional Chinese medicine, a large proportion of patients with HCC have been diagnosed with spleen deficiency (SD) syndrome and treated with tonifying traditional Chinese medicine, which has significant clinical efficacy. However, the role and molecular mechanism of SD in HCC remain unclear. In this study, 40 mice were randomly divided into four groups: control, SD, HCC, and SD-HCC groups. The liver cancer model of SD was established by reserpine induction and orthotopic transplantation. The effects of SD on the proliferation, apoptosis, invasion, and metastasis of HCC cells were studied by cell proliferation, cell apoptosis, cell scratch, and transwell assay. We found that compared with the HCC group, the protein expressions of cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), phosphatase and tensin homolog (PTEN), and AKT (also known as protein kinase B or PKB) in the exosomes of the SD-HCC group were upregulated. In addition, the metastases and self-renewal of exosomes in the SD-HCC group were more aggressive than those in the HCC group, which could be partially reversed with the addition of CTLA-4 inhibitors. Further studies showed that in the internal environment of SD, CTLA-4 promoted tumor invasion and metastasis by regulating the PTEN/CD44 pathway. In conclusion, our findings suggest that during SD in the internal environment, exosome CTLA-4 regulates the PTEN/CD44 signal pathway to promote the proliferation, self-renewal, and metastasis of liver cancer.
引用
- Wang Y, Li P, Mao S, et al. Exosome CTLA-4 Regulates PTEN/CD44 Signal Pathway in Spleen Deficiency Internal Environment to Promote Invasion and Metastasis of Hepatocellular Carcinoma. Front Pharmacol. 2021. PMID: 34744733. doi:10.3389/fphar.2021.757194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。